Login/Sign Up
MRP ₹119500
(Inclusive of all Taxes)
₹11950.0 Cashback (10%)
Provide Delivery Location
About Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection belongs to the group of monoclonal antibodies used in the post-exposure treatment of mild to moderate respiratory illness caused by COVID-19 in people aged 12 years or older, weighing at least 40kgs. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is used in non-hospitalised cases of COVID-19 that are at risk of progressing to severe disease.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection contains Casirivimab and Imdevimab which work by using proteins (monoclonal antibodies) that mimic the natural immune system of the body and fight off the harmful virus. They block the virus attachment and entry into the human cells, thereby preventing the progression of the illness.
A qualified healthcare professional will administer Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection. Do not self-administer. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection may cause certain common side effects such as redness, pain and soreness at the injection site. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
It is advisable to inform the doctor if you are allergic to any of its components. Consult your doctor if you are pregnant, planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is not authorized for use in patients who require oxygen therapy or hospitalisation due to COVID-19.
Uses of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection
Have a query?
Directions for Use
Medicinal Benefits
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection contains monoclonal antibodies used in the post-exposure treatment of mild to moderate disease caused by SARS-CoV-2. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection works by using monoclonal proteins to imitate the natural defence mechanism of the body. The COVID virus contains a capsid with spike proteins, through which it penetrates into the body cells to cause infection. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection binds to the spike protein of the virus. Thereby blocking the spike protein of the virus from attaching to the human receptor cell and arresting the progress of the disease. Hence, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection finds use in preventing the progression of mild to moderate covid cases to severe cases requiring hospitalisation. Thus, Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection finds use in reducing rates of hospitalisation. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection may also be used as post-exposure prophylaxis of coronavirus disease in people who are not fully vaccinated against COVID-19, people with immunocompromising conditions, and in those who are at high risk of being exposed to someone with COVID-19.
How Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection Works
Storage
What if I have taken an overdose of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection
Drug Warnings
It is advisable to inform the doctor if you are allergic to any of its components. Keep your doctor informed if you suffer from any chronic diseasea such as HIV, asthma, cancer, liver disease, kidney problems, heart disease, neurodevelopmental disorders, sickle cell disease or if you have recently had surgery, gastrostomy, tracheostomy or positive pressure ventilation. Offer a detailed medical and vaccination history. Discuss any recent vaccinations with the doctor. Inform the doctor especially if you are on any radiotherapy, immunosuppressant drugs, blood thinners or any other medicines. Consult your doctor if you are planning to get pregnant or are breastfeeding. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is not meant for use as vaccination and in severe hospitalised cases.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
It is not recommended to consume alcohol with Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection. Please consult your doctor if you have any concerns.
Pregnancy
Caution
Not enough studies exist to ascertain the effect of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection on pregnancy. Please consult your doctor if you have any concerns.
Breast Feeding
Caution
Not enough studies exist to ascertain the effect of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection on nursing. Please consult your doctor in case of any concerns.
Driving
Caution
It is not known if Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection affects your ability to drive. Drive only if you are alert.
Liver
Caution
Exercise caution before using Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection in case of established liver disease. Please consult your doctor to address any concerns.
Kidney
Caution
Exercise caution before using Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection in case of established kidney disease. Please consult your doctor to address any concerns.
Children
Caution
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is not recommended for use in children below 12years. Please consult your doctor if you have any concerns.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection belongs to the group of monoclonal antibodies used in the post-exposure treatment of mild to moderate respiratory illness caused by COVID-19 in people aged 12 years or older, weighing at least 40kgs. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is used in non-hospitalised cases of COVID-19 that are at risk of progressing to severe disease.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection works by inducing an antibody response in the body by instilling monoclonal antibodies that mimic the natural defences of the body and block the spike protein of the virus from attaching to body cells, thus arresting the progression of the disease.
Advanced age, obesity, chronic kidney disease, lung disease, sickle cell disease, neurodevelopmental disorders (for example cerebral palsy) and diseases of metabolism are high-risk factors for disease progression.
Not enough literature exists to ascertain the effects of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection on fertility. Please consult your doctor in case of any concerns.
Covid-19 spreads through respiratory droplets when in close or direct contact with an infected person. The virus can spread through an infected person’s sneeze or cough. The virus can also be transmitted by touching any contaminated surfaces and then touching the nose, mouth or eyes without washing the hands.
Vaccines stimulate the body to make its own antibodies against infection. On the other hand, monoclonal antibodies deliver lab-made antibodies against the virus.
Patients with a high risk of developing COVID-19 disease means, those who have certain underlying medical conditions or factors that make them more likely to experience serious illness if they contract COVID-19. These conditions include advanced age, obesity, chronic kidney disease, lung disease, sickle cell disease, neurodevelopmental disorders (for example cerebral palsy) and diseases of metabolism.
An antibody cocktail is a combination of two or more monoclonal antibodies which are separately available but are mixed together. Hence, the name cocktail.
Before taking Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection, inform your doctor if you are allergic to Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection, if you are using prescription and non-prescription medications, vitamins, nutritional supplements, and herbal products. Also, inform your doctor if you have been vaccinated against COVID-19. Discuss the severity and duration of your COVID-19 symptoms to ensure the treatment is appropriate for your condition and also let your doctor know if you are breastfeeding, pregnancy or planning pregnancy.
Monoclonal antibodies are proteins made in a laboratory meant to stimulate immune system. Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection is a treatment that contains two monoclonal antibodies. These antibodies work together to neutralize the SARS-CoV-2 virus by binding to different parts of the virus's spike protein, preventing it from entering human cells.
Monoclonal antibodies neutralize SARS-CoV-2 by binding to its spike protein, preventing virus entry into human cells and reducing viral load, potentially alleviating symptoms and reducing disease severity.
Monoclonal antibody therapy for COVID-19 should be administered as soon as possible and within 5-7 days of symptom onset. Starting the treatment early in the course of the infection is crucial for it to be effective in reducing the risk of severe illness, hospitalization, and death.
Certain individuals should avoid monoclonal antibody therapy for COVID-19, including those who, are allergic to monoclonal antibody treatment, having severe or critical COVID-19 requiring hospitalization, who are seropositive for SARS-CoV-2 antibodies, indicating previous infection. And inform your doctor if you are breastfeeding, pregnant or planning pregnancy. It's important to discuss your medical history and any concerns with your doctor before starting treatment. They can help determine if monoclonal antibody therapy is safe and appropriate for you.
Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection can be administered either intravenously (into a vein) or subcutaneously (under the skin) by a trained healthcare professional in a hospital. Do not self-administer.
If you have high blood pressure and diabetes, you are recommended to take the advice of your doctor before taking Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection. To avoid potential interactions.
The common side effects of Casirivimab / Imdevimab Combo Pack 2400 mg (Regn-COV2) Injection are redness, pain and soreness at the injection site. If any of these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.Prepaid payment required.
We provide you with authentic, trustworthy and relevant information
Buy best Infections & Infestation products by
Cipla Ltd
Macleods Pharmaceuticals Ltd
Alkem Laboratories Ltd
Lupin Ltd
Abbott India Ltd
Sun Pharmaceutical Industries Ltd
Mankind Pharma Pvt Ltd
Aristo Pharmaceuticals Pvt Ltd
Micro Labs Ltd
Intas Pharmaceuticals Ltd
FDC Ltd
Glenmark Pharmaceuticals Ltd
Ipca Laboratories Ltd
Zydus Healthcare Ltd
United Biotech Pvt Ltd
Torrent Pharmaceuticals Ltd
Leeford Healthcare Ltd
Zuventus Healthcare Ltd
Emcure Pharmaceuticals Ltd
Biochem Pharmaceutical Industries Ltd
Hetero Drugs Ltd
Dr Reddy's Laboratories Ltd
Alembic Pharmaceuticals Ltd
Fusion Health Care Pvt Ltd
Indoco Remedies Ltd
Zydus Cadila
Cadila Healthcare Ltd
Wockhardt Ltd
Morepen Laboratories Ltd
AAA Pharma Trade Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Cadila Pharmaceuticals Ltd
Gufic Bioscience Ltd
Elder Pharmaceuticals Ltd
Blue Cross Laboratories Pvt Ltd
Hetero Healthcare Pvt Ltd
Converge Biotech Pvt Ltd
Capital Pharma
Alniche Life Sciences Pvt Ltd
Medishri Healthcare Pvt Ltd
Akumentis Healthcare Ltd
Corona Remedies Pvt Ltd
Apex Laboratories Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Pfizer Ltd
Vasu Organics Pvt Ltd
Wallace Pharmaceuticals Pvt Ltd
Veritaz Healthcare Ltd
Koye Pharmaceuticals Pvt Ltd
Laborate Pharmaceuticals India Ltd
Samarth Life Sciences Pvt Ltd
Unifaith Biotech Pvt Ltd
Hegde & Hegde Pharmaceutica Llp
Shreya Life Sciences Pvt Ltd
Overseas Health Care Pvt Ltd
East West Pharma India Pvt Ltd
Biocon Ltd
Klm Laboratories Pvt Ltd
Lincoln Pharmaceuticals Ltd
Ranbaxy Laboratories Ltd
Biochemix Health Care Pvt Ltd
Canixa Life Sciences Pvt Ltd
Medley Pharmaceuticals Ltd
Pristine Pearl Pharma Pvt Ltd
Ajanta Pharma Ltd
Indchemie Health Specialities Pvt Ltd
Zymes Bioscience Pvt Ltd
Brinton Pharmaceuticals Ltd
German Remedies Ltd
J B Chemicals & Pharmaceuticals Ltd
Natco Pharma Ltd
Unichem International
Yuventis Pharmaceuticals
Aurz Pharmaceutical Pvt Ltd
Neon Laboratories Ltd
Unipark Biotech Pvt Ltd
Icarus Health Care Pvt Ltd
Kivi Labs Ltd
La Renon Healthcare Pvt Ltd
Allites Life Sciences Pvt Ltd
DR Johns Lab Pharma Pvt Ltd
Megma Healthcare Pvt Ltd
Celon Laboratories Pvt Ltd
Kepler Healthcare Pvt Ltd
Medgen Drugs And Laboratories Pvt Ltd
Aionios Pharma Pvt Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Indiabulls Pharmaceuticals Pvt Ltd
Nicholas Piramal India Ltd
Aequitas Healthcare Pvt Ltd
Lividus Pharmaceuticals Pvt Ltd
Novartis India Ltd
Suraksha Pharma Pvt Ltd
Zee Laboratories Ltd
Biological E Ltd
Knoll Healthcare Pvt Ltd
Linux Laboratories Pvt Ltd
Signova Pharma
Systopic Laboratories Pvt Ltd
Unison Pharmaceuticals Pvt Ltd